Cyclosporine a treatment for relapsed subcutaneous panniculitis-like T-cell lymphoma: A case with long-term follow-up

Citations

SCOPUS

12

초록

Subcutaneous panniculitis-like T-cell lymphoma (SPTL) is a distinctive lymphoma characterized by an infiltration of subcutaneous tissue by neoplastic cytotoxic T cells. There was no distinction between TCR alpha/beta phenotype and TCR gamma/delta phenotype, and anthracycline-based chemotherapy was usually used for both. Here, we report a patient with recurrent SPTL who achieved a second long-term complete remission by repeated cyclosporine A (CsA) treatment. From 2000 to 2001, the patient received anthracycline-based combination chemotherapy. However, the treatment did not inducelong-term remission. In 2002, he received cyclosporine treatment for about 6 months. This resulted in a 5-year remission that ended in relapse in 2008. He received CsA treatment once again and attained a second long-term remission. This case suggests that re-treatment with CsA can be a good option for relapsed SPTL cases and can result in long-term remission. ? 2012 Korean Society of Hematology.

키워드

Cyclosporine; Subcutaneous panniculitis-like t-cell lymphoma; Treatment outcome
제목
Cyclosporine a treatment for relapsed subcutaneous panniculitis-like T-cell lymphoma: A case with long-term follow-up
저자
Go, S.-I.; Lee, W.S.; Kang, M.H.; Kim, D.C.; Lee, J.-H.; Kim, I.-S.
DOI
10.5045/kjh.2012.47.2.146
발행일
2012
유형
Article
저널명
Korean Journal of Hematology
권
47
호
2
페이지
146 ~ 149